241 related articles for article (PubMed ID: 11748641)
1. Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas.
Jakobsen AM; Ahlman H; Wängberg B; Kölby L; Bengtsson M; Nilsson O
J Pathol; 2002 Jan; 196(1):44-50. PubMed ID: 11748641
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.
Jakobsen AM; Andersson P; Saglik G; Andersson E; Kölby L; Erickson JD; Forssell-Aronsson E; Wängberg B; Ahlman H; Nilsson O
J Pathol; 2001 Nov; 195(4):463-72. PubMed ID: 11745679
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
[TBL] [Abstract][Full Text] [Related]
5. Synaptic vesicle protein 2, A new neuroendocrine cell marker.
Portela-Gomes GM; Lukinius A; Grimelius L
Am J Pathol; 2000 Oct; 157(4):1299-309. PubMed ID: 11021834
[TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract.
Arvidsson Y; Andersson E; Bergström A; Andersson MK; Altiparmak G; Illerskog AC; Ahlman H; Lamazhapova D; Nilsson O
Endocr Relat Cancer; 2008 Jun; 15(2):569-81. PubMed ID: 18430897
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumors regularly express synaptic vesicle proteins: evidence of a neuroendocrine phenotype.
Bümming P; Nilsson O; Ahlman H; Welbencer A; Andersson MK; Sjölund K; Nilsson B
Endocr Relat Cancer; 2007 Sep; 14(3):853-63. PubMed ID: 17914114
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of secretogranin II in 62 neuroendocrine tumours of the digestive tract and of the pancreas in comparison with other granins.
Le Gall F; Vallet VS; Thomas D; De Monti M; Duval J; Ramee MP
Pathol Res Pract; 1997; 193(3):179-85. PubMed ID: 9198103
[TBL] [Abstract][Full Text] [Related]
9. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
[TBL] [Abstract][Full Text] [Related]
10. NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids.
Jakobsen AM; Ahlman H; Kölby L; Abrahamsson J; Fischer-Colbrie R; Nilsson O
Br J Cancer; 2003 Jun; 88(11):1746-54. PubMed ID: 12771991
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin expression in neuroendocrine tumours of the gastrointestinal tract with multiple endocrine neoplasia type 1.
Raffel A; Krausch M; Cupisti K; Gerharz CD; Eisenberger CF; Knoefel WT
Horm Metab Res; 2005 Oct; 37(10):653-5. PubMed ID: 16278790
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
[TBL] [Abstract][Full Text] [Related]
13. Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors.
Nilsson O; Jakobsen AM; Kölby L; Bernhardt P; Forssell-Aronsson E; Ahlman H
Ann N Y Acad Sci; 2004 Apr; 1014():280-3. PubMed ID: 15153446
[TBL] [Abstract][Full Text] [Related]
14. Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.
Rindi G; Candusso ME; Solcia E
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S135-8. PubMed ID: 10604117
[TBL] [Abstract][Full Text] [Related]
15. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
[TBL] [Abstract][Full Text] [Related]
16. RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours.
Pizzi S; Azzoni C; Bottarelli L; Campanini N; D'Adda T; Pasquali C; Rossi G; Rindi G; Bordi C
J Pathol; 2005 Aug; 206(4):409-16. PubMed ID: 15887288
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract.
Klöppel G; Anlauf M
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):507-17. PubMed ID: 16183524
[TBL] [Abstract][Full Text] [Related]
18. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.
Arnold R
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):491-505. PubMed ID: 16183523
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tumours of the upper gastrointestinal tract and pancreas.
Oberg K; Eriksson B; Lundqvist M
Acta Chir Scand Suppl; 1988; 541():76-85. PubMed ID: 3291522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
